Cargando…

Economics of stem cell transplantation for lymphoma: counting the cost of living

Detalles Bibliográficos
Autor principal:	Sweetenham, J W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363179/ https://www.ncbi.nlm.nih.gov/pubmed/10638957 http://dx.doi.org/10.1054/bjoc.1999.0867

Ejemplares similares

Leukaemia & lymphoma reviews 2
por: Sweetenham, J.W.
Publicado: (1994)

Stem cell transplant for lymphoma - never too late?
por: Cashen, Amanda F., et al.
Publicado: (2022)

Trials in advanced Hodgkin's disease: asking the right questions at the right time
por: Sweetenham, J
Publicado: (2001)

Can we cure relapsed/refractory Hodgkin lymphoma without a stem cell transplant?
por: Mei, Matthew G., et al.
Publicado: (2023)

Is there a role for allogeneic hematopoietic stem cell transplantation for refractory follicular lymphoma?
por: Yang, Yang, et al.
Publicado: (2022)

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?
por: Hackshaw, A, et al.
Publicado: (2004)

Epidemiology, costs, and the economic burden of fibromyalgia
por: Spaeth, Michael
Publicado: (2009)

The costs of the economic crisis in the health sector
por: Radu, Paul, et al.
Publicado: (2009)

The High Cost of Living
Publicado: (1914)

A Live Issue in Medical Economics
Publicado: (1915)

Counting the social, psychological, and economic costs of COVID-19 for cancer patients
por: Kirby, Ann, et al.
Publicado: (2022)

Positron emission tomography-computed tomography before autologous stem cell transplant in follicular lymphoma: coming too late?
por: Sarkozy, Clémentine, et al.
Publicado: (2022)

Counting the Cost: The Economic Toll of Discrimination Against LGBTQAI+ Individuals in Italy
por: Altamura, G, et al.
Publicado: (2023)

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective
por: Reid, Robin M., et al.
Publicado: (2016)

Opportunity cost and COVID-19: A perspective from health economics
por: Olivera, Mario J.
Publicado: (2020)

Fishing Fish Stem Cells and Nuclear Transplants
por: Hong, Yunhan
Publicado: (2011)

Access to hematopoietic stem-cell transplantation in India
por: Kulkarni, U, et al.
Publicado: (2019)

Living in the Extreme: Economics of Pandemics, Climate Change and Tail Risks
por: Boz, Emine, et al.
Publicado: (2022)

Autologous Stem Cell Transplantation for Aggressive Lymphomas
por: Visani, Giuseppe, et al.
Publicado: (2012)

The cost of living: an avoidable public health crisis
por: The Lancet Public Health
Publicado: (2022)

Peripheral Blood Stem Cell Harvest HPC Count Is an Effective Surrogate Marker for CD34+ Cell Count in Allogeneic Stem Cell Transplant Setting
por: Jamal, Aisha, et al.
Publicado: (2020)

Stem cell transplant for mantle cell lymphoma in Taiwan
por: Wang, Yu-Hung, et al.
Publicado: (2022)

Societal Perspectives and Real-World Cost-Effectiveness: Expanding the Scope of Health Economics Inquiry
por: Longo, Christopher J.
Publicado: (2022)

Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies
por: Cenariu, Diana, et al.
Publicado: (2022)

Trivia that Counts
por: Lee, Duk Yong
Publicado: (2011)

Count Rumford
Publicado: (1884)

Death to Carbohydrate Counting?
por: Davis, Nichola J., et al.
Publicado: (2008)

Cancer, health-care backlogs, and the cost-of-living crisis
por: The Lancet Oncology
Publicado: (2022)

Cost of Hematopoietic Stem Cell Transplantation in India
por: Sharma, Sanjeev Kumar, et al.
Publicado: (2014)

Hematopoietic stem cell transplantation for the management of follicular lymphoma
por: Hosing, Chitra
Publicado: (2010)

Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls
por: Mariotti, Jacopo, et al.
Publicado: (2020)

Mature T-cell neoplasms and stem cell transplant: the never-ending story
por: Bachy, Emmanuel
Publicado: (2022)

Producing Stem Cell-Based Transplants for Future Therapeutic Purposes
por: Velasco, Iván, et al.
Publicado: (2017)

Stem cell transplantation for the treatment of end-stage liver disease
por: Wu, Dong-Bo, et al.
Publicado: (2018)

Stem Cell-Based Therapy in Transplantation and Immune-Mediated Diseases
por: Volarevic, Vladislav, et al.
Publicado: (2017)

Editorial: Autologous and Allogeneic Stem Cell Transplant in Cancer Therapy
por: Sharma, Nidhi, et al.
Publicado: (2023)

Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma
por: Rashidi, A, et al.
Publicado: (2015)

Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas
por: Dumont, Maëlle, et al.
Publicado: (2020)

Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
por: Abeyakoon, Chathuri, et al.
Publicado: (2020)

Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
por: Li, Zhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hbktqfpd9mto1fgml1bj6knjg5